Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease
Clinical trial NCT05212779 · UNKNOWN
Trial details
- NCT number
- NCT05212779
- Sponsor
- Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-07
- Primary completion
- 2024-12-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.